A, S., TI, Y., A, N., KS, O., WT, C., WE, B., . . . HA, S. (2022). Long-term outcomes and late toxicity of adult medulloblastoma treated with combined modality therapy: A contemporary single-institution experience. Neuro-oncology, 24(12), 2180. https://doi.org/10.1093/neuonc/noac126
Chicago Style (17th ed.) CitationA, Saraf, et al. "Long-term Outcomes and Late Toxicity of Adult Medulloblastoma Treated with Combined Modality Therapy: A Contemporary Single-institution Experience." Neuro-oncology 24, no. 12 (2022): 2180. https://doi.org/10.1093/neuonc/noac126.
MLA (9th ed.) CitationA, Saraf, et al. "Long-term Outcomes and Late Toxicity of Adult Medulloblastoma Treated with Combined Modality Therapy: A Contemporary Single-institution Experience." Neuro-oncology, vol. 24, no. 12, 2022, p. 2180, https://doi.org/10.1093/neuonc/noac126.